drugset / Trial / NCT00165763
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the efficacy and safety of cholinesterase inhibitor (donepezil hydrochloride) Aricept in patients with vascular dementia (VaD).
Timeline
- Start
- 2005-09
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | — |